ArticleInternal medicine (Tokyo, Japan)2025

Sustained Clinical Complete Response after Discontinuation of Trastuzumab-deruxetecan Due to Interstitial Pneumonia for HER2-positive Gastric Adenocarcinoma with Enteroblastic Differentiation (GAED).

Nobumi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.